BLANCHARD VISION CORP. – Trademark Portfolio
Entity Type: 03
BLANCHARD VISION CORP. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include ONEFIT, RECLAIM HD, ESSENTIAL RGP MULTIFOCAL, and RSS REFRACTIVE SURGERY SPECIFIC. The owner is based in FAREHAM, HAMPSHIRE.
DELTA PARK, CONCORDE WAY
SEGENSWORTH NORTH
FAREHAM, HAMPSHIRE PO155RL , th
Showing of trademarks Trademarks
Trademark Classifications
BLANCHARD VISION CORP.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BLANCHARD VISION CORP. have?
BLANCHARD VISION CORP. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 cancelled.
What trademark classes does BLANCHARD VISION CORP. file in?
BLANCHARD VISION CORP. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are BLANCHARD VISION CORP.'s most well-known trademarks?
BLANCHARD VISION CORP.'s registered trademark portfolio includes well-known marks such as ONEFIT, RECLAIM HD, ESSENTIAL RGP MULTIFOCAL, and RSS REFRACTIVE SURGERY SPECIFIC. These are among 4 currently registered trademarks in the portfolio.
What is BLANCHARD VISION CORP.'s trademark registration success rate?
BLANCHARD VISION CORP. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.